CONMED Corp — Director's Dealing 2019

Sep 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-09-23

Reporting Person: Schwarzentraub Barbara J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-23	Rsus (restricted Stock Units)	$0	A	895	Acquired	2029-09-23	Common Stock (895)	Direct
2019-09-23	Options To Purchase Common Stock	$100.52	A	1515	Acquired	2029-09-23	Common Stock (1515)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting on September 23, 2020 subject to the director's completion of the term of service through the next annual shareholder meeting.

F2: The incentive stock options ("Options") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan with the Options generally vesting on September 23, 2020 subject to the director's completion of the term of service through the next annual shareholder meeting